About Vkyor Medix Private Limited
Data last updated:
Vkyor Medix Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 November 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2022PTC173869. Its GSTIN is 09AAJCV0944N1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Madhu Srivastava and Sharad Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 11 Khasra No 257 Jankipuram Ext, Lucknow, Uttar Pradesh, India – 226013.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.23 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹25,859 (net margin 0.2%) and EBITDA of ₹1.28 Lakh (EBITDA margin 1%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vkyor.in.
Company details
Contact details
Vkyor Medix Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is vkyor.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address11 Khasra No 257 Jankipuram Ext, Lucknow, Uttar Pradesh, India – 226013
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vkyor Medix Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vkyor Medix is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vkyor Medix Private Limited, buy the company report.
Financials of Vkyor Medix Private Limited
FY 2025 filings availableVkyor Medix Private Limited reported revenue of ₹1.23 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 23% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.28 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹25,859 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Vkyor Medix Private Limited, buy the company report.
Board of directors of Vkyor Medix Private Limited
Vkyor Medix has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Srivastava | Director | 23 Nov 2022 | 3 Years 11 Months | Current |
| Sharad Srivastava | Director | 23 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Vkyor Medix Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Restech Formulation Private Limited | ₹1.23 Cr (FY 2022) | 100.0% | Puducherry, India | |||
| Ram Shiv Pharmaceuticals Private Limited | ₹1.23 Cr (FY 2024) | -38.0% | Kanpur, Uttar Pradesh, India | |||
| Biosafe Lifecare Private Limited | ₹1.23 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Lifeguard Pharma Private Limited | ₹1.23 Cr (FY 2021) | 6.0% | Gurgaon, Haryana, India | |||
| Lundbeck India Private Limited | ₹1.23 Cr (FY 2023) | -91.0% | Bangalore, Karnataka, India | |||
| Vkyor Medix Private Limitedthis company | ₹1.23 Cr (FY 2025) | ₹25,859 | 0.2% | 23.0% | Lucknow, Uttar Pradesh, India | |
| Getwell Nutraceuticals India Private Limited | ₹1.23 Cr (FY 2018) | 34.0% | Patna, Bihar, India | |||
| Kripton Biotech Private Limited | ₹1.22 Cr (FY 2025) | 14.0% | Meerut, Uttar Pradesh, India | |||
| Archame Intermediate Private Limited | ₹1.22 Cr (FY 2024) | -22.0% | Sangli, Maharashtra, India | |||
| Sunbeam Photo Chem Private Limited | ₹1.22 Cr (FY 2025) | 128.0% | Ankleshwar, Gujarat, India | |||
| CSV Pharmaceuticals India Private Limited | ₹1.22 Cr (FY 2024) | 4794.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Vkyor Medix Private Limited, buy the company report.
Auditor
Vkyor Medix Private Limited is audited by RAJIV PRIYANKA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV PRIYANKA & ASSOCIATES | FY 2023 | 006513C |
Shareholding
The shareholding of Vkyor Medix Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Vkyor Medix Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vkyor Medix Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vkyor Medix Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vkyor Medix Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Vkyor Medix has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCV0944N1ZQ | Uttar Pradesh | Active | 20 Dec 2022 |
To see the full GST registrations and return filing status of Vkyor Medix Private Limited, buy the company report.
Recent activity
Vkyor Medix Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Madhu Srivastava was appointed as Director on 23 Nov 2022.
Frequently asked questions
Vkyor Medix is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 November 2022 (4+ years old) and is registered under CIN U51909UP2022PTC173869.
Vkyor Medix has 2 current directors:
- Madhu Srivastava - Director
- Sharad Srivastava - Director
The latest financial statements of Vkyor Medix on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Vkyor Medix is 09AAJCV0944N1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Vkyor Medix is U51909UP2022PTC173869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vkyor Medix was incorporated on 23 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Vkyor Medix by revenue are Restech Formulation Private Limited, Ram Shiv Pharmaceuticals Private Limited, Biosafe Lifecare Private Limited, Lifeguard Pharma Private Limited, Lundbeck India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Madhu Srivastava was appointed as Director on 23 Nov 2022. Sharad Srivastava was appointed as Director on 23 Nov 2022.
Vkyor Medix can be reached through the website vkyor.in. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Vkyor Medix is at 11 Khasra No 257 Jankipuram Ext, Lucknow, Uttar Pradesh, India – 226013.
Vkyor Medix operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
